A Single-arm Study Evaluating the Effectiveness and Safety of Suzetrigine (SUZ) for Acute Pain After Selected Surgeries

PHASE4RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 27, 2025

Primary Completion Date

January 1, 2026

Study Completion Date

January 15, 2026

Conditions
Acute Pain
Interventions
DRUG

Suzetrigine

Tablets for oral administration.

Trial Locations (17)

11030

RECRUITING

North Shore University Hospital - Anesthesiology, Manhasset

21218

RECRUITING

MedStar, Baltimore

23502

RECRUITING

Tidewater Clinical Research, Norfolk

27704

RECRUITING

Eximia Research-Durham, Durham

27710

RECRUITING

Duke University Hospital - Anesthesiology, Durham

28207

RECRUITING

OrthoCarolina - Hip & Knee Center, Charlotte

28412

RECRUITING

Seaside Clinical Research Institute, Wilmington

28557

RECRUITING

West Clinical Research, Morehead City

34232

RECRUITING

Gulfcoast Research Institute, Sarasota

37920

RECRUITING

University of Tennessee Medical Center - Anethesiology, Knoxville

44106

RECRUITING

UH Cleveland Medical Center - Anesthesiology, Cleveland

72211

RECRUITING

Woodland International Research Group, Little Rock

77043

RECRUITING

Memorial Hermann Village, Houston

85260

RECRUITING

Scottsdale Clinical Trials, Scottsdale

89121

RECRUITING

Oasis Clinical Research, Las Vegas

08103

RECRUITING

Cooper University HealthCare (CUH), Camden

Texas

RECRUITING

"HD Research LLC , First Surgical Hospital"

All Listed Sponsors
lead

Vertex Pharmaceuticals Incorporated

INDUSTRY